KR101646325B9 - A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom - Google Patents

A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom

Info

Publication number
KR101646325B9
KR101646325B9 KR1020140027856A KR20140027856A KR101646325B9 KR 101646325 B9 KR101646325 B9 KR 101646325B9 KR 1020140027856 A KR1020140027856 A KR 1020140027856A KR 20140027856 A KR20140027856 A KR 20140027856A KR 101646325 B9 KR101646325 B9 KR 101646325B9
Authority
KR
South Korea
Prior art keywords
spirulina
hydrolysate
gastrointestinal
preventing
pharmaceutical composition
Prior art date
Application number
KR1020140027856A
Other languages
Korean (ko)
Other versions
KR101646325B1 (en
KR20150106035A (en
Inventor
정원교
이명기
허성영
Original Assignee
부경대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 부경대학교 산학협력단 filed Critical 부경대학교 산학협력단
Priority to KR1020140027856A priority Critical patent/KR101646325B1/en
Publication of KR20150106035A publication Critical patent/KR20150106035A/en
Application granted granted Critical
Publication of KR101646325B1 publication Critical patent/KR101646325B1/en
Publication of KR101646325B9 publication Critical patent/KR101646325B9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
KR1020140027856A 2014-03-10 2014-03-10 A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom KR101646325B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140027856A KR101646325B1 (en) 2014-03-10 2014-03-10 A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140027856A KR101646325B1 (en) 2014-03-10 2014-03-10 A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom

Publications (3)

Publication Number Publication Date
KR20150106035A KR20150106035A (en) 2015-09-21
KR101646325B1 KR101646325B1 (en) 2016-08-09
KR101646325B9 true KR101646325B9 (en) 2022-03-11

Family

ID=54245001

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140027856A KR101646325B1 (en) 2014-03-10 2014-03-10 A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom

Country Status (1)

Country Link
KR (1) KR101646325B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180089252A (en) 2017-01-31 2018-08-08 정우재 Pharmaceutical composition for preventing or treating of periodontal ligament diseases comprising spirulina extract as an active ingredient
KR102093826B1 (en) 2019-06-18 2020-03-27 정우재 Pharmaceutical composition for preventing or treating of periodontal ligament diseases comprising spirulina extract as an active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297328A (en) * 2006-04-28 2007-11-15 Dainippon Ink & Chem Inc Method for preparing peptide and angiotensin-converting enzyme inhibitor
JP2007295841A (en) * 2006-04-28 2007-11-15 Dainippon Ink & Chem Inc Peptide mixture, and method for preparing peptide
JP2010138133A (en) * 2008-12-12 2010-06-24 Univ Of Tokyo Hypotensive peptide derived from micro algal spirulina and method for producing the same
CN101906135A (en) * 2010-07-27 2010-12-08 鲁军 Novel spirulina source antihypertensive peptide and preparation method thereof

Also Published As

Publication number Publication date
KR101646325B1 (en) 2016-08-09
KR20150106035A (en) 2015-09-21

Similar Documents

Publication Publication Date Title
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
IL268919A (en) Personalised immunogenic peptide identification platform
IL252902A0 (en) Amino acid and peptide conjugates and uses thereof
EP3310373A4 (en) Thiol-ene based peptide stapling and uses thereof
EP3262061C0 (en) Peptides for facilitating secretion and uses thereof
HK1248729A1 (en) Cytotoxic hexim1 peptides and uses thereof
EP3624829A4 (en) Octreotide injection
EP3189849A4 (en) Novel peptide for inhibiting fat accumulation, and pharmaceutical composition for preventing or treating obesity, comprising same
EP3131925A4 (en) Modified relaxin b chain peptides
GB2546439B (en) Ezrin-derived peptides and pharmaceutical compositions thereof
EP3285795A4 (en) Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes
EP3271383A4 (en) Stapled peptides and uses thereof
KR101646325B9 (en) A pharmaceutical composition for preventing and treating hypertension comprising spirulina sp. gastrointestinal hydrolysate and a peptide derived therefrom
EP3190129A4 (en) Centrally-acting peptide derivative, and pharmaceutical composition
HK1251924A1 (en) Foxm1-derived peptide, and vaccine including same
IL251289B (en) Novel peptide derivatives and uses thereof
GB201612150D0 (en) Modified peptide
KR101637640B9 (en) A peptide derived from fermented marine microalgae pavlova lutheri and a pharmaceutical composition for preventing and treating cancer comprising the same
HK1251928A1 (en) Mphosph1-derived peptide, and vaccine including same
LT3171885T (en) Peptide hydrolysate of snails, peptide fractions, production method, use and compositions for inhibiting the angiotensin converting enzyme
AU2014901409A0 (en) Modified relaxin B chain peptides
AU2014901314A0 (en) Modified relaxin B chain peptides

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190730

Year of fee payment: 4